Prevalence of undiagnosed pernicious anemia in the elderly
Injection site rotation Retatrutide is administered subcutaneously, meaning into the fat layer just beneath the skin
Adverse reaction 1) If overdose, the following adverse reactions may occur: Headache, asthenia, fatigue, muscle pain, Loss of appetite, weight loss, growth disorder, nausea, vomiting, constipation, diarrhea, polydipsia, polyuria, dehydration, high blood pressure, calcium oxalate stones, tissue calcification, kidney disease, vascular disease, and kidney failure
After treatment You may notice: Mild muscle soreness Slight tenderness Small redness around the injection site These symptoms normally disappear quickly
What the science says: Because the FDA originally approved sermorelin to treat children with a GH deficiency, medical experts have decades worth of real-world data and clinical use, giving the medication an extremely solid safety profile